Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

What is the role of the 11- to 14-week ultrasound in women with negative cell-free DNA screening for aneuploidy?

10 Jan 2016

Abstract excerpt

OBJECTIVE: This study aimed to examine the role of the 11- to 14-week ultrasound in women with negative cell-free DNA screening. METHODS: A retrospective cohort study of women at increased risk for aneuploidy based on age or medical history and negative cell-free DNA screening between March 2012 and March 2014 was conducted. Patients were included if they had an 11- to 14-week ultrasound and obstetrical care at...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Assisted Reproductive Technology and Twin Pregnancy
Share to Parvovirus B19 Infection Studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26748490
DOI: 10.1002/pd.4774

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

What is the role of the 11- to 14-week ultrasound in women with negative cell-free DNA screening for aneuploidy?PMID 26748490Read ↗

Increased nuchal translucency in fetuses with a normal karyotype—diagnosis and managementSemantic proximity Read ↗

Non-Invasive Prenatal Screening from a Genetic Counseling Prospective: Pre and Post-Genetic Counseling Regarding Rare Chromosomal Abnormalities and Incidental FindingSemantic proximity Read ↗

Noninvasive prenatal testing in the general obstetric population: clinical performance and counseling considerations in over 85 000 casesSemantic proximity Read ↗

Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening?Semantic proximity Read ↗

Patient choice and clinical outcomes following positive noninvasive prenatal screening for aneuploidy with cell-free DNA (cfDNA)Semantic proximity Read ↗

Sex chromosome aneuploidy detection by noninvasive prenatal testing: helpful or hazardous?Semantic proximity Read ↗

Abnormal Nuchal Translucency and Outcomes of Singleton Pregnancies (Antop) Study: An 8 -year Retrospective Cohort AnalysisSemantic proximity Read ↗

Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing.Semantic proximity Read ↗

CMA-first, ES-on-demand for fetuses with absent/hypoplastic nasal bone: a real-world diagnostic pathway and outcomes in 362 fetusesSemantic proximity Read ↗

NSGC Practice Guideline: Prenatal Screening and Diagnostic Testing Options for Chromosome AneuploidySemantic proximity Read ↗

Society for Maternal-Fetal Medicine Consult Series #57: Evaluation and management of isolated soft ultrasound markers for aneuploidy in the second trimesterSemantic proximity Read ↗

Practice Bulletin No. 163Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.